Where leukemia comes from
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Leukemia has no single origin story the way an infection does. There is no organism that arrived, no first case to trace.
What there is instead is a structural explanation: the body built a tissue that has to replace itself constantly, and constant replacement has a price.
Related pages: Leukemia (blood cancer)
The bottom line
- Leukemia arises from copying errors in blood-forming cells, which divide throughout life.
- Pre-leukemic clones are common in older people and usually never progress.
- Childhood ALL often begins with a mutation before birth and needs a second event afterwards.
- Leukemia is ancient; it is not caused by modern life, though some modern exposures raise risk.
- How much of leukemia risk is random copying error versus environmental exposure.
- What the second event is in childhood ALL, where an infection-related trigger is the leading hypothesis.
The story, step by step
What the evidence labels mean
A tissue that can never stop
What happens
Blood is the most rapidly renewed tissue in the body, and that is the root of the problem.
What the research shows
- Red cells last about four months, platelets about ten days, neutrophils about a day.
- To keep up, the marrow produces hundreds of billions of cells daily, every one of them copied from a parent cell.
- Each copy carries a small chance of error. Multiply a small chance by that volume over a lifetime and errors are guaranteed.
- Tissues that renew fastest, blood, gut lining and skin, are also the tissues where cancer is most common. That is not coincidence.
Why it matters
Leukemia is in part the price of a blood system that can heal, fight infection and replace itself. The same property that makes it resilient makes it vulnerable.
What's still uncertain
- Exactly what proportion of cancers is attributable to unavoidable copying error is contested and the estimates vary widely.
Read more
- NCI: LeukemiaGovernment
Next: Clonal hematopoiesis
Most people are on the road and never arrive
What happens
Modern sequencing revealed something nobody expected: mutated clones are common in healthy people.
What the research shows
- In older adults, a substantial proportion carry a blood cell clone with a leukemia-associated mutation, most often in DNMT3A, TET2 or ASXL1.
- This state, clonal hematopoiesis of indeterminate potential, causes no symptoms and is usually found incidentally.
- The large majority of people with it never develop a blood cancer. The annual rate of progression is low.
- It does carry a measurable increase in risk, both of blood cancer and, unexpectedly, of cardiovascular disease, apparently through inflammation.
Why it matters
This reframes leukemia as the end of a long road that many people walk partway down without ever knowing it.
What's still uncertain
- There is no treatment for clonal hematopoiesis and no evidence that screening for it helps.
Read more
- NCI: LeukemiaGovernment
- OwieClear: How mutations hijack blood stem cellsOwieClear
Next: Before birth
The childhood leukemias start early
What happens
Childhood ALL follows a different pattern, and the evidence for it is unusually elegant.
What the research shows
- Identical twins who share a placenta can share a leukemic clone: when one twin develops ALL, the pre-leukemic cells can be found in the other, showing the first mutation happened in the womb and crossed between them.
- Blood spots collected at birth from children who later developed ALL have been found to contain the same fusion gene years before diagnosis.
- Studies suggest the pre-leukemic clone is far more common at birth than leukemia itself, so most children carrying it never develop the disease.
- A second genetic event after birth is therefore required.
Why it matters
It means childhood leukemia begins before the child is born, which rules out most of the things parents blame themselves for.
What's still uncertain
- Estimates of how many newborns carry a pre-leukemic clone vary between studies and methods.
Read more
Next: The second hit
The hypothesis that fits the epidemiology
What happens
What triggers the second event is the central unanswered question.
What the research shows
- The leading proposal, developed by Mel Greaves over decades, is that an immune system without enough early microbial exposure responds abnormally to a later common infection.
- The observations that support it: lower rates among children with early daycare attendance or older siblings, higher rates in affluent populations with less early infectious exposure, and clusters after unusual population mixing.
- It does not implicate any single virus. It is about the pattern of early immune training, not one germ.
- It remains unproven, and no preventive intervention follows from it yet, though research into early immune priming continues.
Why it matters
This is a hypothesis with good supporting epidemiology and no direct proof, and it should be read that way rather than as established fact.
What's still uncertain
- Confounding is difficult to exclude in studies of this kind, and alternative explanations remain plausible.
Read more
Next: Not new
Leukemia in the historical record
What happens
The idea that leukemia is a modern disease does not survive contact with the evidence.
What the research shows
- Skeletal remains with changes consistent with leukemia have been described from antiquity, though such diagnoses are necessarily uncertain.
- Blood cancers occur in many other mammals and in birds, which is what you would expect of a disease rooted in cell division rather than in human lifestyle.
- Apparent increases in incidence over the last century are substantially explained by longer lifespans, better diagnosis and the fact that leukemia was simply not recognized before the microscope.
- That said, some genuine increases are documented, including therapy-related leukemias, which did not exist before cancer treatment did.
Why it matters
The honest summary is that leukemia is old and inherent, and that a minority of cases have identifiable modern causes.
What's still uncertain
- Historical and archaeological diagnoses of leukemia cannot be confirmed and should be treated cautiously.
Read more
- NCI: LeukemiaGovernment
- OwieClear: When leukemia was first identifiedOwieClear